Picture of Zai Lab logo

ZLAB — Zai Lab News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Zai Lab Announces Breakthrough Therapy Designation Granted For Repotrectinib

Aug 30 (Reuters) - Zai Lab Ltd  9688.HK :
    * ZAI LAB ANNOUNCES BREAKTHROUGH THERAPY DESIGNATION GRANTED
FOR
REPOTRECTINIB FOR TREATMENT OF PATIENTS WITH NTRK-POSITIVE
TKI-PRETREATED ADVANCED SOLID TUMORS IN CHINA

Source text for Eikon:  ID:nGNX3hprlT 
Further company coverage:  9688.HK

Recent news on Zai Lab

See all news